InvestmentMay 27, 2026, 08:22 AM
BNB Plus Secures $4.1M Initial Commitments for Strategic Financing
AI Summary
BNB Plus Corp. has secured initial commitments for $4.1 million in convertible preferred stock financing, aiming for total proceeds of $5.0 million. This financing will bolster the company's digital asset treasury and provide working capital for a comprehensive strategic review of its digital asset and biotechnology businesses, led by GlobalStake Infrastructure. Following the anticipated proceeds, the company expects to hold over $16.4 million in cash and digital assets, and its LineaRx subsidiary achieved profitability in Q2 FY2026.
Key Highlights
- Secured initial commitments for $4.1 million in convertible preferred stock financing.
- Targeting $5.0 million in total proceeds from the financing.
- Expected to hold over $16.4 million in cash and digital assets after financing.
- First $2.3 million of proceeds for strategic review of biotech assets and general corporate purposes.
- Series B-1 Preferred Stock priced at $1.05 per share, a 176% premium over May 22 closing price.
- Series B-1 Preferred Stock carries an 8.0% annual dividend and 1.5x liquidation preference.
- Series B-2 Preferred Stock priced at $0.38 per share, with a 6.0% annual dividend and 1.0x liquidation preference.
- LineaRx subsidiary achieved profitability in Q2 FY2026.
Price Impact
More from BNBX